Drug Class
long-acting muscarinic antagonist
Type
brand
Active Ingredient
revefenacin
📋Overview
Yupelri is a prescription medication containing revefenacin, which is classified as a long-acting muscarinic antagonist (LAMA). It is primarily used in the management of chronic obstructive pulmonary disease (COPD), a group of lung conditions that cause breathing difficulties. Yupelri works by helping to relax the muscles around the airways, making it easier to breathe for people with chronic lung diseases.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Yupelri
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.